XPH icon

SPDR S&P Pharmaceuticals ETF

80 hedge funds and large institutions have $185M invested in SPDR S&P Pharmaceuticals ETF in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 18 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$981K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$53.7M
2 +$6.24M
3 +$2.3M
4
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$1.49M
5
Jane Street
Jane Street
New York
+$1.32M

Top Sellers

1 -$7.62M
2 -$5.74M
3 -$5.63M
4
Morgan Stanley
Morgan Stanley
New York
-$5.25M
5
Wells Fargo
Wells Fargo
California
-$3.96M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$53.7M
2
$30.1M
3
$29.4M
4
$14.6M
5
$8.21M
6
$6.48M
7
$4.36M
8
$4.17M
9
$3.23M
10
$3.02M
11
$2.3M
12
$1.99M
13
$1.95M
14
$1.49M
15
$1.42M
16
$1.32M
17
$1.29M
18
$1.25M
19
$1.19M
20
$1.17M
21
$961K
22
$916K
23
$751K
24
$732K
25
$676K